pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
VIR-5500
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$VIR
Vir Biotechnology, Inc.
0
catalysts
Phase 1
VIR-5525
Adenocarcinoma
$VIR
Vir Biotechnology, Inc.
0
catalysts
Phase 1
VIS-171
Autoimmune Disorders
Visterra Inc
0
catalysts
Phase 1
← prev
page 146 of 231
next →
131
Pain
89
Neurology
1
VIS-954
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
Visterra Inc
0
catalysts
Preclinical
VIS-DerMap
Basal Cell Carcinoma (Basal Cell Epithelioma)
ArrayPatch Ltd
0
catalysts
VISINE ALLERGY EYE RELIEF MULTI-ACTION
VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)
KENVUE BRANDS
0
catalysts
VISIONBLUE
VISIONBLUE (TRYPAN BLUE)
DORC
0
catalysts
VITRAKVI
VITRAKVI (LAROTRECTINIB)
BAYER HLTHCARE
0
catalysts
Phase 1
VK-0214
Adrenomyeloneuropathy (AMN)
$VIK
Viking Holdings Ltd
0
catalysts
Phase 2
VK-5211
Bone Fracture
Androgen receptor
$VIK
Viking Holdings Ltd
0
catalysts
Phase 2
VL-PX10 + VL-P22
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Vitti Labs LLC
0
catalysts
Phase 3
VLA-15
Lyme Disease
$VALN
Valneva SE
0
catalysts
Phase 2
VLP-001
Peanut Allergy
Allergy Therapeutics Plc
0
catalysts
Phase 2
VLPM-01
Malaria
VLP Therapeutics LLC
0
catalysts
Phase 2
VLS-1488
Ovarian Cancer
Volastra Therapeutics Inc
0
catalysts
Phase 1
VMPAIN-004
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathet…
Vivamed BioPharma
0
catalysts
Phase 2
VMPSY-002
Substance (Drug) Abuse
Vivamed BioPharma
0
catalysts
Phase 2
VMPSY-003
Opium (Opioid) Addiction
Vivamed BioPharma
0
catalysts
Phase 2
VMT-01
Metastatic Melanoma
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Phase 2
VMT-a-NET
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Preclinical
VNLG-152
Triple-Negative Breast Cancer (TNBC)
Isoprene Pharmaceuticals Inc
0
catalysts
Preclinical
VNRX-6355
Neisseria gonorrhoeae Infections
VenatoRx Pharmaceuticals Inc
0
catalysts
Phase 2
VNX-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Vironexis Biotherapeutics Inc
0
catalysts
Phase 2
VNX-202
Gastric Cancer
Vironexis Biotherapeutics Inc
0
catalysts
Phase 2
VP-001
Retinitis Pigmentosa (Retinitis)
PYC Therapeutics Ltd
0
catalysts
Preclinical
VPD-380
Pulmonary Arterial Hypertension
Corsair Pharma Inc
0
catalysts
Phase 2
VR-101
Female Contraception
VaRi Bioscience GmbH
0
catalysts
Phase 2
VR-103
Endometriosis
VaRi Bioscience GmbH
0
catalysts
Preclinical
VRG-145
Migraine
VRG Therapeutics Ltd
0
catalysts
Preclinical
VS-01
Hyperammonemia
Genfit SA
0
catalysts
